TY - JOUR AU - Trang, Tran Huyen AU - Thanh, Nguyen Tat AU - Nguyen, Nguyen Minh AU - Dung, Nguyen Anh AU - Hai, Hoang Bui PY - 2022/12/28 Y2 - 2024/03/28 TI - 3. Extracorporeal membrane oxygenation for Covid-19 associated severe acute respiratory distress syndrome JF - Tạp chí Nghiên cứu Y học JA - TCNCYH VL - 161 IS - 12E11 SE - DO - 10.52852/tcncyh.v161i12E11.980 UR - https://tapchinghiencuuyhoc.vn/index.php/tcncyh/article/view/980 SP - 20-26 AB - <p class="p1"><em>COVID-19<span class="Apple-converted-space">&nbsp; </span>caused significant mortality worldwide, including in Vietnam. This study aimed to evaluate the effectiveness of Extracorporeal membrane oxygenation (ECMO) in the treatment of COVID-19 patients with acute respiratory distress syndrome (ARDS). From January 1, 2022 to March 31, 2022, the COVID-19 hospital admitted 395 critical patients, including 10 patients required veno-venous Extracorporeal membrane oxygenation (VV-ECMO). This descriptive study revealed relatively high survival rate of 60% (6/10 patients) with the median duration of ECMO was 11.5 days. The study group's SOFA and RESP scores were 6 and 4, respectively. Time from symptom onset to mechanical ventilation, duration of NIV and/or HFNC before mechanical ventilation, time from symptom onset to ECMO of the study patients were 9.5, 0 and 11.5 days, respectively. The most common complication in ECMO patients was nosocomial infection (70%), in addition to bleeding, embolism, or both at the same time. This preliminary research showed that ECMO was effective in the management of acute respiratory distress syndrome in patients with COVID-19.</em></p> ER -